nodes	percent_of_prediction	percent_of_DWPC	metapath
Allylestrenol—PGR—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.0699	0.0699	CbGpPWpGaD
Allylestrenol—PGR—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.0553	0.0553	CbGpPWpGaD
Allylestrenol—PGR—Nuclear signaling by ERBB4—GFAP—amyotrophic lateral sclerosis	0.0548	0.0548	CbGpPWpGaD
Allylestrenol—ESR1—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.041	0.041	CbGpPWpGaD
Allylestrenol—ESR1—Signaling mediated by p38-alpha and p38-beta—RAB5A—amyotrophic lateral sclerosis	0.0408	0.0408	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—GRN—amyotrophic lateral sclerosis	0.0342	0.0342	CbGpPWpGaD
Allylestrenol—ESR1—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.0324	0.0324	CbGpPWpGaD
Allylestrenol—ESR1—Nuclear signaling by ERBB4—GFAP—amyotrophic lateral sclerosis	0.0321	0.0321	CbGpPWpGaD
Allylestrenol—PGR—Nuclear signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.0284	0.0284	CbGpPWpGaD
Allylestrenol—ESR1—LKB1 signaling events—MAPT—amyotrophic lateral sclerosis	0.0256	0.0256	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.024	0.024	CbGpPWpGaD
Allylestrenol—ESR1—Signaling mediated by p38-alpha and p38-beta—ATF1—amyotrophic lateral sclerosis	0.0223	0.0223	CbGpPWpGaD
Allylestrenol—PGR—Validated nuclear estrogen receptor alpha network—SOD1—amyotrophic lateral sclerosis	0.0201	0.0201	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—GFAP—amyotrophic lateral sclerosis	0.0184	0.0184	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.0182	0.0182	CbGpPWpGaD
Allylestrenol—ESR1—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—amyotrophic lateral sclerosis	0.0171	0.0171	CbGpPWpGaD
Allylestrenol—ESR1—Nuclear signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.0167	0.0167	CbGpPWpGaD
Allylestrenol—PGR—Validated nuclear estrogen receptor alpha network—C3—amyotrophic lateral sclerosis	0.0159	0.0159	CbGpPWpGaD
Allylestrenol—ESR1—FOXA1 transcription factor network—SOD1—amyotrophic lateral sclerosis	0.0159	0.0159	CbGpPWpGaD
Allylestrenol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.0146	0.0146	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.0141	0.0141	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.0138	0.0138	CbGpPWpGaD
Allylestrenol—ESR1—Validated nuclear estrogen receptor alpha network—SOD1—amyotrophic lateral sclerosis	0.0118	0.0118	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.0115	0.0115	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.0113	0.0113	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—CASP9—amyotrophic lateral sclerosis	0.0112	0.0112	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—GFAP—amyotrophic lateral sclerosis	0.0108	0.0108	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.0107	0.0107	CbGpPWpGaD
Allylestrenol—ESR1—Plasma membrane estrogen receptor signaling—IGF1—amyotrophic lateral sclerosis	0.0103	0.0103	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.00982	0.00982	CbGpPWpGaD
Allylestrenol—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—amyotrophic lateral sclerosis	0.00965	0.00965	CbGpPWpGaD
Allylestrenol—PGR—Signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.00958	0.00958	CbGpPWpGaD
Allylestrenol—PGR—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.00955	0.00955	CbGpPWpGaD
Allylestrenol—ESR1—Validated nuclear estrogen receptor alpha network—C3—amyotrophic lateral sclerosis	0.00933	0.00933	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.00875	0.00875	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00776	0.00776	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.00775	0.00775	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00753	0.00753	CbGpPWpGaD
Allylestrenol—ESR1—Plasma membrane estrogen receptor signaling—MMP9—amyotrophic lateral sclerosis	0.00746	0.00746	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00708	0.00708	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.00693	0.00693	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.00678	0.00678	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.0066	0.0066	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—CASP9—amyotrophic lateral sclerosis	0.00657	0.00657	CbGpPWpGaD
Allylestrenol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.00611	0.00611	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.00607	0.00607	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.00576	0.00576	CbGpPWpGaD
Allylestrenol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	0.00574	0.00574	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—FUS—amyotrophic lateral sclerosis	0.00564	0.00564	CbGpPWpGaD
Allylestrenol—ESR1—Signaling by ERBB4—ERBB4—amyotrophic lateral sclerosis	0.00562	0.00562	CbGpPWpGaD
Allylestrenol—ESR1—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.0056	0.0056	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00547	0.00547	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.00546	0.00546	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.00514	0.00514	CbGpPWpGaD
Allylestrenol—ESR1—LKB1 signaling events—TP53—amyotrophic lateral sclerosis	0.00487	0.00487	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—MMP9—amyotrophic lateral sclerosis	0.00486	0.00486	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.00461	0.00461	CbGpPWpGaD
Allylestrenol—PGR—Gene Expression—RARA—amyotrophic lateral sclerosis	0.0046	0.0046	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.0044	0.0044	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.0038	0.0038	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.00356	0.00356	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—FUS—amyotrophic lateral sclerosis	0.00331	0.00331	CbGpPWpGaD
Allylestrenol—ESR1—AP-1 transcription factor network—TP53—amyotrophic lateral sclerosis	0.0033	0.0033	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.00321	0.00321	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.00312	0.00312	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.00299	0.00299	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00293	0.00293	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00278	0.00278	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00278	0.00278	CbGpPWpGaD
Allylestrenol—ESR1—Gene Expression—RARA—amyotrophic lateral sclerosis	0.0027	0.0027	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00269	0.00269	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.00248	0.00248	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00239	0.00239	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00236	0.00236	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.00236	0.00236	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.0023	0.0023	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.00196	0.00196	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.00183	0.00183	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.00178	0.00178	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00172	0.00172	CbGpPWpGaD
Allylestrenol—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.0017	0.0017	CbGpPWpGaD
Allylestrenol—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00168	0.00168	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00163	0.00163	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.00162	0.00162	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00158	0.00158	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00152	0.00152	CbGpPWpGaD
Allylestrenol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.00148	0.00148	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00145	0.00145	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.0014	0.0014	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00139	0.00139	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.0013	0.0013	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.0013	0.0013	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.00124	0.00124	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00119	0.00119	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.00117	0.00117	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00111	0.00111	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00104	0.00104	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.00103	0.00103	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.00096	0.00096	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000953	0.000953	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000941	0.000941	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000893	0.000893	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000851	0.000851	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000793	0.000793	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000728	0.000728	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000713	0.000713	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000685	0.000685	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	0.000658	0.000658	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000611	0.000611	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000605	0.000605	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000577	0.000577	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000563	0.000563	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000541	0.000541	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000518	0.000518	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000466	0.000466	CbGpPWpGaD
Allylestrenol—PGR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.000392	0.000392	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000358	0.000358	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000339	0.000339	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000304	0.000304	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000291	0.000291	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000267	0.000267	CbGpPWpGaD
Allylestrenol—ESR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.00023	0.00023	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	0.00022	0.00022	CbGpPWpGaD
Allylestrenol—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000151	0.000151	CbGpPWpGaD
